Nachrichten zur ABBVIE Aktie

Can AbbVie Stock Keep Outpacing the S&P 500? @themotleyfool #stocks $ABBV

AbbVie has been a surprisingly strong performer of late. Can the stock keep it up?…

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock…

AbbVie (ABBV) Parkinsons Candidate Faces 2nd FDA Rejection

AbbVie (ABBV) issues the second CRL for Parkinsons disease medicine, ABBV-951, based on some observations on inspection of one of…

Global Contraceptive Drugs Market Size To Worth USD 40.08 Billion By 2033 | CAGR Of 8.02%

The Global Contraceptive Drugs Market Size was Valued at USD 18.53 Billion in 2023 and the Worldwide Contraceptive Drugs Market…

Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41%

The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…

AbbVie sets quarterly dividend at $1.55 per share By Investing.com

AbbVie sets quarterly dividend at $1.55 per share…

AbbVie declares $1.55 dividend

…

Pharma Stock Roundup: FDA Nod to MRKs New Jab & Expanded Use of ABBV & AZN Drugs

FDA approves Mercks (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVies (ABBV) Skyrizi and AstraZenecas (AZN)…

AbbVie: Stabübergabe in der Immunologie - Aktienanalyse

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies in 2024

Alzheimer’s disease treatment stocks are focused on Alzheimer’s disease, a degenerative brain disorder that results in declining memory and thinking…

AbbVies (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis

AbbVies (ABBV) Skyrizi is now approved for four indications across immune-mediated inflammatory diseases.…

AbbVie: 5 Reasons That Make A Buy Case

…

AbbVie: Neues Kursziel - Aktienanalyse

Minneapolis (www.aktiencheck.de) - AbbVie-Aktienanalyse von Piper Sandler: Piper Sandler erhöht in einer aktuellen Aktienanalyse das Kursziel für die Aktie von AbbVie…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Global Prostate Health Market Size To Worth USD 78.03 Billion By 2033 | CAGR Of 9.12%

The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…

CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your Rights

NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating…

AbbVies tight grip on Humira market raises concerns about biosimilars By Reuters

AbbVies tight grip on Humira market raises concerns about biosimilars…

Pharma Stock Roundup: LLYs CFO Departs, ABBV, AZN Drugs Get CHMP Approval

Eli Lillys (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVies (ABBV) Skyrizi and AstraZenecas (AZN) Tagrisso.…

AbbVies (ABBV) Ovarian Cancer Therapy Meets Study Goal

Data from a mid-stage study shows that treatment with AbbVies (ABBV) Elahere achieves an objective response rate of almost 52%…

AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

The late-stage study will evaluate AbbVies (ABBV) experimental antibody to treat patients with relapsed/refractory multiple myeloma who have received at…

S&P 500-Wert AbbVie-Aktie: So viel Gewinn hätte eine Investition in AbbVie von vor einem Jahr abgeworfen

Heute vor 1 Jahr wurden AbbVie-Anteile wochenend-bedingt nicht via Börse NYSE gehandelt. Der Schlusskurs der AbbVie-Aktie betrug am vorangegangen…

AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

AbbVie (ABBV) announces that the EMAs CHMP issued a positive opinion on its regulatory filing seeking label expansion for the…

CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer

NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating…

Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%

The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…

Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered

…

Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?

Investors need to pay close attention to AbbVie (ABBV) stock based on the movements in the options market lately.…

Forget Nvidia, Buy This Magnificent Healthcare Stock Instead

AbbVies returns havent been great this year, but investors shouldnt overlook this promising growth stock.…

CERE (NASDAQ) ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation; Contact BFA Law to Discuss Your Rights

NEW YORK, May 25, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating…

BaseLaunch geht Partnerschaft mit AbbVie ein

Basel - Der Basler Accelerator und Inkubator BaseLaunch, der neue Biotechfirmen in ihrer Frühphase finanziert und unterstützt, hat den US-Pharmakonzern…

BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by AbbVie, Contact the Firm for Details

NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bleichmar Fonti & Auld LLP is investigating the merger between…

[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

AbbVie-Aktie mit leichten Kursgewinnen (152,8600 €)

Im Plus liegt zur Stunde die AbbVie-Aktie . Zuletzt zahlten Investoren für die Aktie 166,22 US-Dollar. Freuen können sich gegenwärtig…

Non Hodgkin Lymphoma (NHL) Global Market Report 2024: Asia-Pacific Set for Swift Growth Amidst Advancements in Immunotherapy and Diagnostic Tools

Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Non Hodgkin Lymphoma (NHL) Global Market Report 2024" report has…

Pharmalittle: Were reading about fake studies, AbbVie investing in psychedelics, and more

Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost…

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal

AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.…

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJs New Plan to Resolve Talc Claims

Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.…

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Groups CEO will testify…

AbbVie investiert rund 150 Millionen Euro in die Zukunft der Spitzenforschung am Standort Ludwigshafen

AbbVie Deutschland GmbH & Co. KG: Ludwigshafen (ots) - - Modernste Rahmenbedingungen für Forscher*innen im Kampf gegen u.a. Alzheimer und…

AbbVie: Diversifizierung auf Schiene - Aktienanalyse

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…